The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.
1135 ET – Pfizer CEO Albert Bourla says in an interview with CNBC that he expects to pay the full contingent value right in the company’s acquisition of weight-loss drug startup Metsera. “I have seen data, and I think that the probability that those molecules will succeed and get approval is very, very high,” he says. Pfizer has said that it will leverage the scale of its global clinical, manufacturing and commercial infrastructure to accelerate Metsera’s portfolio. (connor.hart@wsj.com)
Copyright ©2025 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8